Home / Curated GI articles May 28th, 2021: AI in GI startup Docbot funding $8.5M | Gastro Health valuation mid-$900m
AI impressive as a second set of eyes in colonoscopy (AIinHealthcare)
Researchers have developed a deep convolutional neural network that can identify colorectal polyps with 90% accuracy while ruling out 80% of false flags.
Scope Forward podcast – CEO of Bold Health (digital GI company) (Episode 26)
Listen to the interviews on the move! Praveen Suthrum’s conversations with GI leaders are now available via the Scope Forward podcast on Apple Podcasts, Spotify and elsewhere.
Interview: CEO of Bold Health: “We seek to cover all GI conditions you might want to see a doctor for” (NextServices)
Elena Mustatea is the CEO and founder of Bold Health, a digital GI company that delivers digital therapeutics for the treatment of various GI conditions such as IBS.
What are the most rewarding, challenging factors for gastroenterologists? (Becker’s GI & Endoscopy)
Most gastroenterologists say making the world a better place or finding diagnoses for patients are the most rewarding aspects of their job.
Private equity thriving in gastroenterology: 9 updates (Becker’s GI & Endoscopy)
Private equity has seen consistent success in gastroenterology, with firms like One GI acquiring at least three firms since the start of 2021.
OMERS buys Audax’s Gastro Health at mid-$900m valuation (PE Hub)
Being a first-mover is proving advantageous, with Audax one of the first private equity entrants in GI physician practice management as a result of its early 2016 investment.
How gastroenterologist pay has changed in the past 10 years (Becker’s GI & Endoscopy)
Gastroenterology has consistently been among the top 10 highest-earning specialties in the U.S., with an average annual salary of $406,000 in 2021.
Engine and Giiant Scoop Up Fresh Funding for Cancer and IBD (BioSpace)
After a $10 million seed round in 2018, Engine Biosciences announced its first VC round – a $43 million Series A.
Geneoscopy Announces Publication of Peer-Reviewed Article (BusinessWire)
The article reports high sensitivity of the company’s noninvasive, at-home diagnostic screening test to successfully detect colorectal neoplasms, in average-risk individuals within the intended use population for CRC.
USPSTF Recommendations Guide Payers on Preventive Care Screenings (Health Payer Intelligence)
The latest US Preventive Services Task Force recommendations addressed hypertension, colorectal cancer, and vitamin D deficiency preventive care screenings.
EndoFresh’s disposable endoscopy system greenlighted by FDA (Becker’s GI & Endoscopy)
The device’s approval comes following reports by the FDA on cross contamination risks associated with urological endoscopes and duodenoscopes.
AI Toilet Tool Offers Remote Patient Monitoring for Gastrointestinal Health (mHealth Intelligence)
Duke University is developing an artificial intelligence software tool for toilets that uses remote patient monitoring to help manage gastrointestinal issues.
Probiotics: A Review for Clinical Use (Gastroenterology & Endoscopy News)
Just how probiotics may affect various conditions is not completely understood, but several mechanisms have been proposed.
COVID-19’s Gut Connection -How MIS-C complication develops in children, adolescents (Harvard Medical School)
The syndrome can occur several weeks after an initial infection. Symptoms include high fever, abdominal pain, vomiting, diarrhea, rash, and extreme fatigue.
Video: DDW chair recaps noteworthy abstracts from virtual meeting (Healio)
Loren Laine, MD, FACG, chair of the Digestive Disease Week counsel, Yale School of Medicine, highlighted a few presentations from Digestive Disease Week.
Colonoscopies Restricted by Pandemic: Worse CRC Outcomes to Come? (Medscape)
After COVID-19 screening policies were implemented, a significantly lower rate of veterans with red-flag signs or symptoms for CRC underwent colonoscopy.
15 Need-to-Know Presentations From DDW 2021 (Medscape)
“We must consider raising our expectations for FIT-positive patients as well as looking for serrated lesions in mt-sDNA-positive patients.” – A Commentary by David A. Johnson, MD.
AI in GI startup Docbot funding $8.5M (Fierce Biotech)
Docbot aims to hit the ground running with a Series A cash infusion and a new CEO—and move forward with clinical trials of its real-time artificial intelligence programs for spotting potential cancers during colonoscopy.
More Hot headlines in GI